Figure 4 shows the pedigrees of the three index cases (17.6%) found to be compound heterozygous for SCN5A mutations, with an onset of symptoms in early childhood (younger than age 4 years), overlap syndrome and prolonged QTc intervals. Here, SCN5A is linked to overlapping connective tissue disease.